Breaking News - The Fly

Open Search

URGN

UroGen Pharma

$

()

UroGen Pharma announces FDA acceptance of UGM-103 IND

URGN

4/15/2024 - 08:07am

UroGen Pharma files patent infringement action against Teva Pharmaceuticals

URGN

4/3/2024 - 08:02am

UroGen Pharma price target lowered by $1 at Oppenheimer, here's why

URGN

3/15/2024 - 07:52am

UroGen Pharma price target raised by $3 at Oppenheimer, here's why

URGN

1/24/2024 - 08:34am

UroGen initiates submission of rolling NDA to FDA for UGN-102

URGN

1/24/2024 - 08:15am

UroGen in deal with medac GmbH to develop formulation for urothelial cancers

URGN

1/17/2024 - 08:04am

UroGen Pharma announces rolling NDA submission for UGN-102 to begin in January

URGN

10/3/2023 - 08:03am

UroGen Pharma files to sell 12.58M ordinary shares for holders

URGN

9/8/2023 - 16:23pm

TD Cowen biotech analyst to hold an analyst/industry conference call

URGN

8/16/2023 - 14:50pm

TD Cowen biotech analyst to hold an analyst/industry conference call

URGN

8/16/2023 - 11:34am

UroGen Pharma sees FY23 JELMYTO revenue $76M-$86M

URGN

8/10/2023 - 08:08am

UroGen Pharma reports Q2 EPS ($1.03) vs. ($1.18) last year

URGN

8/10/2023 - 08:06am

UroGen Pharma price target raised to $54 from $23 at H.C. Wainwright

URGN

8/1/2023 - 06:14am

UroGen Pharma price target raised to $52 from $47 at Ladenburg

URGN

7/31/2023 - 06:44am

UroGen Pharma price target raised to $33 from $22 at Oppenheimer

URGN

7/28/2023 - 08:38am